Let’s explore “persistent inflammation”

This report overview covers Th17 and Th22 cells, epithelial barriers, IL-22R1, IL-10R2, and the source’s discussion of skin, gut, and lung tissues.

This report overview covers the p19 and p40 subunits, interleukin-23, and the report’s distinction between the IL23A gene and the IL23R receptor.

This report overview covers interleukin-23 receptor, JAK2, TYK2, STAT3, and the immune-signaling pathways discussed in the source report.

This report overview covers interleukin-2 receptor alpha, regulatory T cells, soluble IL-2 receptor, and the T-cell activation vocabulary used in the report.

This report overview covers epithelial alarmins, the ST2 receptor, ILC2 cells, IL-5, IL-13, and the report’s discussion of type 2 immunity.

This report overview covers interleukin-4, Th2 cells, immunoglobulin E (IgE), and the report’s discussion of allergic and atopic conditions.

This report overview covers interleukin-6, C-reactive protein (CRP), the acute-phase response, rheumatoid arthritis, and the conditions discussed in the report.

This report overview covers interleukin-8, neutrophils, CXCR1, CXCR2, and the report’s discussion of immune-cell recruitment.

This report overview covers sIL2R, sCD25, soluble interleukin-2 receptor, T-cell activation, and the report’s discussion of sarcoidosis.

This report overview covers transforming growth factor-beta 1, tissue repair, fibrosis, systemic sclerosis, and the report’s discussion of scarring.

This report overview covers Toll-like receptor 2, microbial and damage signals, TLR1, TLR6, and MyD88 signaling.

This report overview covers death receptor 4, TRAIL-R1, TRAIL, apoptosis, and the report’s discussion of programmed cell death.